Literature DB >> 11555403

Effector cytolotic function but not IFN-gamma production in cytotoxic T cells triggered by virus-infected target cells in vitro.

M Regner1, M Lobigs, R V Blanden, A Müllbacher.   

Abstract

Cytolysis and interferon(IFN)-gamma production are two independent effector functions of activated cytotoxic T (Tc) cells. We have used the Tc-cell response against the flavivirus, Murray Valley encephalitis virus (MVE), to investigate the requirements for inducing these two functions with regard to antigen-concentration and CD8 coreceptor involvement. Cognate peptide-pulsed target cells triggered cytolysis by primary ex vivo MVE-immune as well as in vitro peptide-restimulated splenocytes at lower peptide concentrations than IFNgamma-production (100-fold lower in the case of primary ex vivo effectors). Little difference was observed in CD8 dependency. Importantly, neither of the effector populations were triggered to produce IFN-gamma by virus-infected target cells, although cytolysis occurred. This result raises the possibility that the levels of presentation of cognate antigen on virus-infected cells in vivo may be below the threshold required for the IFN-gamma production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555403     DOI: 10.1046/j.1365-3083.2001.00955.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  Fas/FasL and perforin-granzyme pathways mediated T cell cytotoxic responses in infectious bursal disease virus infected chickens.

Authors:  Abdul Rauf; Mahesh Khatri; Maria V Murgia; Yehia M Saif
Journal:  Results Immunol       Date:  2012-05-16

2.  Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system.

Authors:  Bimmi Shrestha; Michael S Diamond
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

3.  CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis.

Authors:  Yang Wang; Mario Lobigs; Eva Lee; Arno Müllbacher
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  Avidity characterization of genetically engineered T-cells with novel and established approaches.

Authors:  Victoria Hillerdal; Vanessa F Boura; Hanna Björkelund; Karl Andersson; Magnus Essand
Journal:  BMC Immunol       Date:  2016-07-13       Impact factor: 3.615

5.  The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity.

Authors:  Kimberly Shafer-Weaver; Thomas Sayers; Susan Strobl; Eric Derby; Tracy Ulderich; Michael Baseler; Anatoli Malyguine
Journal:  J Transl Med       Date:  2003-12-29       Impact factor: 5.531

6.  Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay.

Authors:  Kimberly A Shafer-Weaver; Thomas Sayers; Douglas B Kuhns; Susan L Strobl; Mark W Burkett; Michael Baseler; Anatoli Malyguine
Journal:  J Transl Med       Date:  2004-09-20       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.